Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Peptide mimicry breaks the heart: Myocarditis, a prolonged chronic inflammation of heart muscle, can eventually progress to inflammatory cardiomyopathy, a serious condition associated with heart failure. Activated T helper (T H ) cells that recognize myosin heavy chain 6–derived peptides are thought to play a central role in this pathogenesis. Using a mouse model of myocarditis, Gil-Cruz et al. found that cardiac myosin–reactive T H cells are initially primed by myosin-peptide mimics derived from commensal Bacteroides species in the gut (see the Perspective by Epelman). Unlike heathy controls, human myocarditis patients also showed detectable immune reactivity to both Bacteroides and cardiac myosin antigens. Treatment with antibiotics dampened inflammatory responses and prevented lethal heart disease. Science , this issue p. 881 ; see also p. 806
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The cross-reactivity of α -MyHC-specific T cells is further supported by findings that these T cells also recognize commensal Bacteroides species. 283”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [283]
In the citing paper
“Animal models of myocarditis have yielded a wealth of information about the pathogenesis of disease including a number of landmark articles that demonstrate that myocarditis is an autoimmune disease that requires TLR activation by microbes. 44,152,153”
From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [44]
In the citing paper
“Yet recent data identified cross-reactivity between a B. thetaiotaomicron β–galactosidase and myosin peptide associated with development of cardiomyopathy in genetically susceptible individuals (31).”
From A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint Inhibitors (2021) · cites this paper as [31]
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
Johnson, D. B., Balko, J. M., Compton, M. L., Chalkias, S., Gorham, J., Xu, Y., Hicks, M., Puzanov, I., Alexander, M. R., Bloomer, T. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1609214 · Cited by 2,308
Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans
Vatanen, T., Kostic, A. D., d’Hennezel, E., Siljander, H., Franzosa, E. A., Yassour, M., Kolde, R., Vlamakis, H., Arthur, T. D., Hämäläinen, A.-M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.007 · Cited by 1,289
Davidson, A., & Diamond, B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108023450506 · Cited by 1,042
(2006) · Elsevier eBooks · doi:10.1016/b978-0-12-595961-2.x5000-8 · Cited by 962
Weintraub, R. G., Semsarian, C., & Macdonald, P. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31713-5 · Cited by 649
Innate and Adaptive Humoral Responses Coat Distinct Commensal Bacteria with Immunoglobulin A
Bunker, J. J., Flynn, T. M., Koval, J. C., Shaw, D. G., Meisel, M., McDonald, B. D., Ishizuka, I. E., Dent, A. L., Wilson, P. C., Jabri, B., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.08.007 · Cited by 555
Guidelines for the use of flow cytometry and cell sorting in immunological studies *
Cossarizza, A., Chang, H., Radbruch, A., Akdis, M., Andrä, I., Annunziato, F., Bacher, P., Barnaba, V., Battistini, L., Bauer, W. M., et al. (2017) · European Journal of Immunology · doi:10.1002/eji.201646632 · Cited by 542
Cardiac myosin induces myocarditis in genetically predisposed mice.
Neu, N., Rose, N. R., Beisel, K. W., Herskowitz, A., Gurri-Glass, G., & Craig, S. W. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.11.3630 · Cited by 526
Cited by
The microbiome and human cancer
Sepich-Poore, G. D., Zitvogel, L., Straussman, R., Hasty, J., Wargo, J. A., & Knight, R. (2021) · Science · doi:10.1126/science.abc4552 · Cited by 1,332
“thetaiotaomicron–derived b-galactosidase and host cardiac myosin heavy chain 6 could drive lethal autoimmune inflammatory cardiomyopathy (79); conversely, Nanjundappa and others reported how cross-reactivity between Bacteroides species–derived integrase and host islet-specific glucose-6-phosphatase catalytic subunit-r…”
BackgroundGut Bacteroides species in health and disease
Zafar, H., & Saier, M. H. (2021) · Gut Microbes · doi:10.1080/19490976.2020.1848158 · Cited by 1,233
“has revealed that Bth may also play an important role in the occurrence of this condition.(155) The authors found that Bth encodes a cross-reactive β-galactosidase mimic peptide, which can activate myosin-specific T-cells in the gut and can also induce a humoral response involving IgA and IgG in response to gut commen…”
BackgroundMyocarditis and inflammatory cardiomyopathy: current evidence and future directions
Tschöpe, C., Ammirati, E., Bozkurt, B., Caforio, A. L. P., Cooper, L. T., Felix, S. B., Hare, J. M., Heidecker, B., Heymans, S., Hübner, N., et al. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00435-x · Cited by 1,217
The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology
Rutsch, A., Kantsjö, J. B., & Ronchi, F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.604179 · Cited by 821
“Interestingly, among those, there are also diseases affecting host organs in physical distance from the gut (8, 9), like the central nervous system (CNS) (7, 10–22).”
BackgroundSelf-citationHost–microbiota interactions in immune-mediated diseases
Ruff, W. E., Greiling, T. M., & Kriegel, M. A. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0367-2 · Cited by 487
Gut microbiota and cardiovascular disease: opportunities and challenges
Kazemian, N., Mahmoudi, M., Halperin, F., Wu, J. C., & Pakpour, S. (2020) · Microbiome · doi:10.1186/s40168-020-00821-0 · Cited by 384
Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage
Fluckiger, A., Daillère, R., Sassi, M., Sixt, B. S., Liu, P., Loos, F., Richard, C., Rabu, C., Alou, M. T., Goubet, A.-G., et al. (2020) · Science · doi:10.1126/science.aax0701 · Cited by 396
T cells specific for α-myosin drive immunotherapy-related myocarditis
Axelrod, M. L., Meijers, W. C., Screever, E. M., Qin, J., Carroll, M. G., Sun, X., Tannous, E., Zhang, Y., Sugiura, A., Taylor, B. C., et al. (2022) · Nature · doi:10.1038/s41586-022-05432-3 · Cited by 367
Ma, Z., Zuo, T., Frey, N., & Rangrez, A. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01946-6 · Cited by 259
“613 Recent research has identi fi ed several novel enzymes in the gut microbiota that have similar functions to those found in the host (Microbial-host-isozyme).”
BackgroundCancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes
Ting, N. L.-N., Lau, H. C.-H., & Yu, J. (2022) · Gut · doi:10.1136/gutjnl-2021-326264 · Cited by 274
“107 108 Considering the diversified proteome in the gut microbiota, 109 110 more microbial antigens with high homology to cancer antigens would likely be discovered.”
BackgroundBasso, C. (2022) · New England Journal of Medicine · doi:10.1056/nejmra2114478 · Cited by 225
Immune checkpoint inhibitor–associated myocarditis: manifestations and mechanisms
Moslehi, J., Lichtman, A. H., Sharpe, A. H., Galluzzi, L., & Kitsis, R. N. (2021) · Journal of Clinical Investigation · doi:10.1172/jci145186 · Cited by 237
Sanchez-Rodriguez, E., Egea-Zorrilla, A., Plaza-Díaz, J., Aragón-Vela, J., Muñoz-Quezada, S., Tercedor-Sánchez, L., & Abadia-Molina, F. (2020) · Nutrients · doi:10.3390/nu12030605 · Cited by 214
“reported that mimic peptides from commensal bacteria can promote inflammatory cardiomyopathy in genetically susceptible individuals [181].”
BackgroundWang, M., Rousseau, B., Qiu, K., Huang, G., Zhang, Y., Su, H., Le Bihan-Benjamin, C., Khati, I., Artz, O., Foote, M. B., et al. (2024) · Nature Biotechnology · doi:10.1038/s41587-023-01957-8 · Cited by 211
“Fecal microbiota transplantation improved the immune microenvironment and improved the checkpoint inhibitor response in immunotherapy-refractory patients with melanoma 58 .”
Commensal bacteria stimulate antitumor responses via T cell cross-reactivity
Bessell, C. A., Isser, A., Havel, J. J., Lee, S., Bell, D. R., Hickey, J. W., Chaisawangwong, W., Glick Bieler, J., Srivastava, R., Kuo, F., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.135597 · Cited by 184
The epithelial barrier theory and its associated diseases
Sun, N., Ogulur, I., Mitamura, Y., Yazici, D., Pat, Y., Bu, X., Li, M., Zhu, X., Babayev, H., Ardicli, S., et al. (2024) · Allergy · doi:10.1111/all.16318 · Cited by 173
COVID-19, Myocarditis and Pericarditis
Fairweather, D., Beetler, D. J., Di Florio, D. N., Musigk, N., Heidecker, B., & Cooper, L. T. (2023) · Circulation Research · doi:10.1161/circresaha.123.321878 · Cited by 194
Microbial-host-isozyme analyses reveal microbial DPP4 as a potential antidiabetic target
Wang, K., Zhang, Z., Hang, J., Liu, J., Guo, F., Ding, Y., Li, M., Nie, Q., Lin, J., Zhuo, Y., et al. (2023) · Science · doi:10.1126/science.add5787 · Cited by 173
Towards modulating the gut microbiota to enhance the efficacy of immune-checkpoint inhibitors
Simpson, R. C., Shanahan, E. R., Scolyer, R. A., & Long, G. V. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00803-9 · Cited by 153
Carrillo-Salinas, F. J., Anastasiou, M., Ngwenyama, N., Kaur, K., Tai, A., Smolgovsky, S. A., Jetton, D., Aronovitz, M., & Alcaide, P. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1823801 · Cited by 143
“These results suggest that T cell activation in response to TAC is not imprinted in the gut by commensal Bacteroides, something recently described in a spontaneous model of cardiac autoimmunity.(15) While we do not identify the specific mechanism of T cell activation by bacteria or whether specific bacterial antigenic…”
ResultAn overview of the immune mechanisms of viral myocarditis
Lasrado, N., & Reddy, J. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2131 · Cited by 138
“possibly because gut microbes could potentially trigger such responses by cross-reactivity in genetically susceptible individuals.(166) It would be”
BackgroundWon, T., Kalinoski, H. M., Wood, M. K., Hughes, D. M., Jaime, C. M., Delgado, P., Talor, M. V., Lasrado, N., Reddy, J., & Čiháková, D. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111611 · Cited by 137
“69,70 In this study, we tested only cardiac myosin as an autoantigen responsible for ICI-associated myocarditis development.”
In situ targeted base editing of bacteria in the mouse gut
Brödel, A. K., Charpenay, L. H., Galtier, M., Fuche, F. J., Terrasse, R., Poquet, C., Havránek, J., Pignotti, S., Krawczyk, A., Arraou, M., et al. (2024) · Nature · doi:10.1038/s41586-024-07681-w · Cited by 125
Immunometabolic mechanisms of heart failure with preserved ejection fraction
Schiattarella, G. G., Alcaide, P., Condorelli, G., Gillette, T. G., Heymans, S. R. B., Jones, E. A. V., Kallikourdis, M., Lichtman, A. H., Marelli‐Berg, F. M., Shah, S. J., et al. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00032-w · Cited by 142
Holistic Approach to Immune Checkpoint Inhibitor-Related Adverse Events
Poto, R., Troiani, T., Criscuolo, G., Marone, G., Ciardiello, F., Tocchetti, C. G., & Varricchi, G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.804597 · Cited by 145
“Moreover, microbiota-derived peptides from Bacteroides induced autoimmune myocarditis (73).”
BackgroundTowards a mechanistic understanding of reciprocal drug–microbiome interactions
Zimmermann, M., Patil, K. R., Typas, A., & Maier, L. (2021) · Molecular Systems Biology · doi:10.15252/msb.202010116 · Cited by 121
“Microbial communities can interact with and affect the host with peptides/proteins (Gil-Cruz et al , 2019), RNA (Liu et al , 2016), and metabolites (Uchimura et al , 2018; Koh & B € ackhed, 2020).”
Dilated cardiomyopathy and chronic cardiac inflammation: Pathogenesis, diagnosis and therapy
Harding, D., Chong, M. H. A., Lahoti, N., Bigogno, C. M., Prema, R., MOHIDDIN, S. A., & Marelli‐Berg, F. M. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13556 · Cited by 118
A gut microbial peptide and molecular mimicry in the pathogenesis of type 1 diabetes
Girdhar, K., Huang, Q., Chow, I., Vatanen, T., Brady, C., Raisingani, A., Autissier, P., Atkinson, M. A., Kwok, W. W., Kahn, C. R., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2120028119 · Cited by 110
Predictive Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Events
Les, I., Martínez, M., Pérez-Francisco, I., Cabero, M., Teijeira, L., Arrazubi, V., Torrego, N., Campillo-Calatayud, A., Elejalde, I., Kochan, G., et al. (2023) · Cancers · doi:10.3390/cancers15051629 · Cited by 100
Mamic, P., Chaikijurajai, T., & Tang, W. H. W. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.12.001 · Cited by 106
“However, this only occurred in patients with an HLA variant known to recognize both MYH6 and betagalactosidase, suggesting disease development resulting from a combination of GMB and host genetic predisposition [88].”
BackgroundThe gut-liver-kidney axis: Novel regulator of fatty liver associated chronic kidney disease
Raj, D., Tomar, B., Lahiri, A., & Mulay, S. R. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104617 · Cited by 104
Myopathic Cardiac Genotypes Increase Risk for Myocarditis
Kontorovich, A. R., Patel, N., Moscati, A., Richter, F., Peter, I., Purevjav, E., Selejan, S. R., Kindermann, I., Towbin, J. A., Bohm, M., et al. (2021) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2021.06.001 · Cited by 95
“Modifiers may include sex (28), gut microbiome (29), vitamins, and trace elements (30), as seen in animal models.”
BackgroundTocchetti, C. G., Ameri, P., de Boer, R. A., D’Alessandra, Y., Russo, M., Sorriento, D., Ciccarelli, M., Kiss, B., Bertrand, L., Dawson, D. K., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa222 · Cited by 100
Lin, H., Meng, L., Sun, Z., Shiming, S., Huang, X., Lin, N., Zhang, J., Lu, W., Yang, Q., Chi, J., et al. (2021) · Circulation Heart Failure · doi:10.1161/circheartfailure.120.008220 · Cited by 85
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis
Fenioux, C., Abbar, B., Boussouar, S., Bretagne, M., Power, J. R., Moslehi, J. J., Gougis, P., Amelin, D., Dechartres, A., Lehmann, L. H., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02591-2 · Cited by 83
Can we harness the microbiota to enhance the efficacy of cancer immunotherapy?
Finlay, B. B., Goldszmid, R., Honda, K., Trinchieri, G., Wargo, J., & Zitvogel, L. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0374-6 · Cited by 81
Myocarditis: Etiology, Pathogenesis, and Their Implications in Clinical Practice
Brociek, E., Tymińska, A., Giordani, A. S., Caforio, A. L. P., Wojnicz, R., Grabowski, M., & Ozierański, K. (2023) · Biology · doi:10.3390/biology12060874 · Cited by 92
Martens, P., Cooper, L. T., & Tang, W. H. W. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.031454 · Cited by 76
Research progress on the relationship between intestinal microecology and intestinal bowel disease
Fu, Q.-H., Song, T., Ma, X., & Cui, J. (2022) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12262 · Cited by 84
Biomarkers for Myocarditis and Inflammatory Cardiomyopathy
Suresh, A., Martens, P., & Tang, W. H. W. (2022) · Current Heart Failure Reports · doi:10.1007/s11897-022-00569-8 · Cited by 69
Adding insult to injury - Inflammation at the heart of cardiac fibrosis
Smolgovsky, S. A., Ibeh, U., Tamayo, T. P., & Alcaide, P. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109828 · Cited by 73
Fibroblastic reticular cell lineage convergence in Peyer’s patches governs intestinal immunity
Prados, A., Onder, L., Cheng, H., Mörbe, U., Lütge, M., Gil‐Cruz, C., Perez‐Shibayama, C., Koliaraki, V., Ludewig, B., & Kollias, G. A. (2021) · Nature Immunology · doi:10.1038/s41590-021-00894-5 · Cited by 68
Self-citationFunctional diversity of cardiac macrophages in health and disease
Yang, S. H., Penna, V. R., & Lavine, K. J. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01109-8 · Cited by 72
“…the activation of autoreactive CD4 + T cells in a fixed T cell receptor model (in which all T cells are reactive to only one antigen) of myocarditis 65 and the discovery of a CD8 + T cell clone specific for α-myosin heavy chain that was shown to be necessary to drive the disease in Pdcd1 −/− Ctla4…”
Wang, W., Li, X., Ding, X., Xiong, S., Hu, Z.-L., Lu, X., Zhang, K., Zhang, H., Hu, Q., Lai, K. S., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.07.019 · Cited by 71
Sequence meets function—microbiota and cardiovascular disease
Kim, M., Huda, M. N., & Bennett, B. J. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab030 · Cited by 66
CXCR3+ T cells in multiple sclerosis correlate with reduced diversity of the gut microbiome
Choileáin, S. N., Kleinewietfeld, M., Raddassi, K., Hafler, D. A., Ruff, W. E., & Longbrake, E. E. (2019) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2019.100032 · Cited by 68
Ciccarelli, M., Dawson, D. K., Falcão‐Pires, I., Giacca, M., Hamdani, N., Heymans, S. R. B., Hooghiemstra, A. M., Leeuwis, A. E., Hermkens, D. M. A., Tocchetti, C. G., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab009 · Cited by 67
“These cells induce heart inflammation and dysfunction in genetically susceptible individuals.(157) Importantly, patients with HF exhibit modifications in the composition and diversity of the intestinal microbiome.”
BackgroundBacillus Calmette–Guérin Immunotherapy for Cancer
Cardillo, F., Bonfim, M., Sousa-Vasconcelos, P. D. S., Mengel, J., Castello-Branco, L. R. R., & Pinho, R. T. (2021) · Vaccines · doi:10.3390/vaccines9050439 · Cited by 65
“Of course, peptide cross-reactivity would be dependent on the Human leukocyte antigens/Major Histocompatibilty (HLA/MHC) haplotype association [90,91].”
BackgroundImmunomodulating Therapies in Acute Myocarditis and Recurrent/Acute Pericarditis
Ammirati, E., Bizzi, E., Veronese, G., Groh, M., Heyning, C. M. V. D., Lehtonen, J. Y. A., de Chambrun, M. P., Cereda, A. F., Picchi, C., Trotta, L., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.838564 · Cited by 68
“Molecular mimicry between viral and cardiac antigens is suspected to be a key mechanism of myocardial injury in virus-triggered AM (27, 28).”
BackgroundRolski, F., Tkacz, K., Węglarczyk, K., Kwiatkowski, G., Pelczar, P., Jaźwa, A., Bar, A., Kuster, G. M., Chłopicki, S., Siedlar, M., et al. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad158 · Cited by 64
“44,45 Furthermore, commensal bacteria were recently shown to boost heart-specific T cell response and cause lethal inflammatory cardiomyopathy, 46 further underlining the destructive potential of unleashed heart-reactive T cells.”
Gut Microbiota and Antitumor Immunity: Potential Mechanisms for Clinical Effect
Baruch, E. N., Wang, J., & Wargo, J. A. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0877 · Cited by 58
“Bacteroides thetaiotaomicron– activated Th1 and Th17 cells have been reported to have a key role in lethal inflammatory cardiomyopathy in mice, and this was abrogated in GF mice and could be mitigated by antibiotic therapy (17).”
BackgroundT cells in cardiac health and disease
Martín, P., & Sánchez‐Madrid, F. (2025) · Journal of Clinical Investigation · doi:10.1172/jci185218 · Cited by 65
“Cross-reactivity with commensal mimic peptides, as highlighted by a recent study (29), can exacerbate the activation of MYH6-specific T cells, leading to enhanced autoimmune responses.”
Myocardial Milieu Favors Local Differentiation of Regulatory T Cells
Delgobo, M., Weiß, E., Ashour, D., Richter, L., Popiolkowski, L., Arampatzi, P., Stangl, V., Arias-Loza, P., Mariotti-Ferrandiz, E., Rainer, P. P., et al. (2023) · Circulation Research · doi:10.1161/circresaha.122.322183 · Cited by 57
Self-citationHealth implication of lactose intolerance and updates on its dietary management
Li, A., Zheng, J., Han, X., Jiang, Z., Yang, B., Yang, S., Zhou, W., Li, C., & Sun, M. (2023) · International Dairy Journal · doi:10.1016/j.idairyj.2023.105608 · Cited by 66
The healing myocardium mobilizes a distinct B-cell subset through a CXCL13-CXCR5-dependent mechanism
Heinrichs, M., Ashour, D., Siegel, J., Büchner, L., Wedekind, G., Heinze, K. G., Arampatzi, P., Saliba, A., Cochain, C., Hofmann, U., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab181 · Cited by 63
Self-citationImmunopathogenesis and immunomodulatory therapy for myocarditis
He, W., Zhou, L. D., Xu, K., Li, H., Wang, J. J., Chen, C., & Wang, D. W. (2023) · Science China Life Sciences · doi:10.1007/s11427-022-2273-3 · Cited by 51
“immune response to a virus and cardiac-specific autoimmune response (Błyszczuk, 2019; Gil-Cruz et al., 2019).”
BackgroundCardiac Fibroblastic Niches in Homeostasis and Inflammation
Cadosch, N., Gil‐Cruz, C., Perez‐Shibayama, C., & Ludewig, B. (2024) · Circulation Research · doi:10.1161/circresaha.124.323892 · Cited by 55
“108,109 Such heart-specific CD4 + T cells are initially activated in the mediastinal lymph nodes and are guided by fibroblast-derived chemokines CCL19, CCL5, and CX3CL1 into the heart 5,111 (Figure 3B).”
Self-citationMolecular fingerprints of cardiovascular toxicities of immune checkpoint inhibitors
Gergely, T. G., Drobni, Z. D., Sayour, N. V., Ferdinandy, P., & Varga, Z. V. (2024) · Basic Research in Cardiology · doi:10.1007/s00395-024-01068-8 · Cited by 55
Clinical Characteristics and Mechanisms of Acute Myocarditis
Heymans, S. R. B., Linthout, S. V., Kraus, S., Cooper, L. T., & Ntusi, N. (2024) · Circulation Research · doi:10.1161/circresaha.124.324674 · Cited by 57
“58 A commensal Bacteroides species peptide from the microbiome mimics the human MYH6614-629 peptide, binding to HLA-DQA1*/B1* and thereby priming cardiac myosin-reactive TH cells.”
BackgroundInfluentialAutoimmune Myocarditis, Old Dogs and New Tricks.
Won, T., Song, E. J., Kalinoski, H. M., Moslehi, J. J., & Čiháková, D. (2024) · Circulation Research · doi:10.1161/circresaha.124.323816 · Cited by 51
“283 Interestingly, heart autoantigens can be recognized by pathogen-specific T cells due to molecular mimicry.”
Gut Microbiome-Based Management of Patients With Heart Failure
Mamic, P., Snyder, M. P., & Tang, W. H. W. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.02.045 · Cited by 53
Harness the functions of gut microbiome in tumorigenesis for cancer treatment
Lee, M. (2021) · Cancer Communications · doi:10.1002/cac2.12200 · Cited by 50
Gut microbiota and their metabolites in cardiovascular disease
Jansen, V. L. B. I., Gerdes, V. E. A., Middeldorp, S., & van Mens, T. E. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101492 · Cited by 54
Falcão‐Pires, I., Ferreira, A. F., Trindade, F., Bertrand, L., Ciccarelli, M., Visco, V., Dawson, D. K., Hamdani, N., Laake, L. W. V., Lezoualc’h, F., et al. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3264 · Cited by 50
The role of gut microbiome in modulating response to immune checkpoint inhibitor therapy in cancer
Naqash, A. R., Kihn-Alarcón, A. J., Stavraka, C., Kerrigan, K. C., Vareki, S. M., Pinato, D. J., & Puri, S. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-6427 · Cited by 54
“…of genetically predisposed myocarditis patients or susceptible patients undergoing ICPI treatment through antibiotics to reduce bacteria-induced immunoreactivity may alleviate disease severity and may, therefore, help prevent the potentially lethal sequelae of inflammatory cardiomyopathy (43).”
Circulating c-Met–Expressing Memory T Cells Define Cardiac Autoimmunity
Fanti, S., Stephenson, E., Rocha-Vieira, E., Protonotarios, A., Kanoni, S., Shahaj, E., Longhi, M. P., Vyas, V. S., Dyer, C., Pontarini, E., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.055610 · Cited by 44
“13,14 In addition, the identification of an immunophenotype linked with clinical disease progression in human myocarditis has remained elusive.”
Shaikh, F. Y., White, J. R., Gills, J. J., Hakozaki, T., Richard, C., Routy, B., Okuma, Y., Usyk, M., Pandey, A., Weber, J. S., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4834 · Cited by 44
Terminally Differentiated CD4+ T Cells Promote Myocardial Inflammaging
Delgobo, M., Heinrichs, M., Hapke, N., Ashour, D., Appel, M., Srivastava, M., Heckel, T., Spyridopoulos, I., Hofmann, U., Frantz, S., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.584538 · Cited by 43
“HLA genotyping was performed by the Institute for Clinical Transfusion Medicine and Haemotherapy from the University Hospital of Würzburg as previously described (16), and only CD4 T cells from matching healthy donors (i.”
MethodSelf-citationAdvancing lifelong precision medicine for cardiovascular diseases through gut microbiota modulation
Shi, B., Li, H., & He, X. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2323237 · Cited by 47
“116 Therefore, the administration of antibiotics to genetically susceptible patients receiving immune checkpoint inhibitors may potentially prevent myocarditis.”
BackgroundFriend or foe? Lactobacillus in the context of autoimmune disease
Fine, R. L., Mubiru, D. L., & Kriegel, M. A. (2020) · Advances in immunology · doi:10.1016/bs.ai.2020.02.002 · Cited by 46
Papadopoulos, P., Tsigalou, C., Valsamaki, P. N., Konstantinidis, T. G., Voidarou, C. C., & Bezirtzoglou, E. (2022) · Biomedicines · doi:10.3390/biomedicines10050948 · Cited by 42
“Specific host immune responses that participate in CVD and have been elucidated, also include the Th17 response [63] and IL-22 pathway [64].”
BackgroundInnate and adaptive immunity in acute myocarditis
Golino, M., Harding, D., Buono, M. G. D., Fanti, S., MOHIDDIN, S. A., Toldo, S. A., Smyth, J. W., Sanna, T., Marelli‐Berg, F. M., & Abbate, A. (2024) · International Journal of Cardiology · doi:10.1016/j.ijcard.2024.131901 · Cited by 45
Non-mutational neoantigens in disease
Stern, L. J., Clement, C. C., Galluzzi, L., & Santambrogio, L. (2024) · Nature Immunology · doi:10.1038/s41590-023-01664-1 · Cited by 46
“Similarly, inflammatory cardiomyopathy seems to be promoted by cardiac myosin-specific T helper 17 (T H 17) cells elicited in the intestine by a commensal Bacteroides spp. epitope 22 .”
Microbiota-induced T cell plasticity enables immune-mediated tumour control
Najar, T. A., Hao, Y., Hao, Y., Romero‐Meza, G., Dolynuk, A., Almo, E., & Littman, D. R. (2026) · Nature · doi:10.1038/s41586-025-09913-z · Cited by 39
“Previous studies have highlighted the potential significance of cross-reactivity between microbial antigens and tumour-associated antigens in cancers 29,47 or autoantigens in auto-immune diseases such as myocarditis, lupus and rheumatoid arthritis 46,48–51 .”
Steffens, S., Linthout, S. V., Sluijter, J. P. G., Tocchetti, C. G., Thum, T., & Madonna, R. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa137 · Cited by 38
Microbial modulation of intestinal T helper cell responses and implications for disease and therapy
Geuking, M. B., & Burkhard, R. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-00335-w · Cited by 39
Self-citationCardiovascular Complications of Viral Respiratory Infections and COVID-19
Franczuk, P., Tkaczyszyn, M., Kulak, M., Domenico, E., Ponikowski, P. P., & Jankowska, E. A. (2022) · Biomedicines · doi:10.3390/biomedicines11010071 · Cited by 42
Myocardial Inflammation as a Manifestation of Genetic Cardiomyopathies: From Bedside to the Bench
Peretto, G., Sommariva, E., Di Resta, C., Rabino, M., Villatore, A., Lazzeroni, D., Sala, S., Pompilio, G., & Cooper, L. T. (2023) · Biomolecules · doi:10.3390/biom13040646 · Cited by 37
Gut microbiota: an emerging target connecting polycystic ovarian syndrome and insulin resistance
Mei, Y., Li, W., Wang, B., Chen, Z., Wu, X., Lin, Y., & Wang, M. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1508893 · Cited by 43
Perez-Shibayama, C., Gil-Cruz, C., Cadosch, N., Lütge, M., Cheng, H.-W., De Martin, A., Frischmann, K., Joachimbauer, A., Onder, L., Papadopoulou, I., et al. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00432-0 · Cited by 35
“Cells were stimulated with 0.25 µg of the MYH6 614–629 peptide (RSLKLMATLFSTYASADR, GenScript) or phorbol myristate acetate (50 ng ml −1 , Sigma-Aldrich)/ionomycin (500 ng ml −1 , Sigma-Aldrich) as positive control or were left untreated.”
InfluentialSelf-citationMicrobiome influencers of checkpoint blockade–associated toxicity
Wang, Y., Jenq, R. R., Wargo, J. A., & Watowich, S. S. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20220948 · Cited by 37
“Bacterial Ags that mimic tissue Ags and drive tissue inflammation have been identified in diseases such as inflammatory cardiomyopathy or autoimmune diabetes (Gil-Cruz et al., 2019; Girdhar et al., 2022).”
BackgroundElevated Neutrophil-to-Lymphocyte Ratio Predicts Prognosis in Acute Myocarditis
Cannata, A. N., Segev, A., Madaudo, C., Bobbio, E., Baggio, C., Schütze, J., Gentile, P., Sanguineti, M., Monzo, L., Schettino, M., et al. (2025) · JACC Heart Failure · doi:10.1016/j.jchf.2024.11.003 · Cited by 39
Gerdes, V. E. A., Gueimonde, M., Pajunen, L., Nieuwdorp, M., & Laitinen, K. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.08.028 · Cited by 39
Gastrointestinal microbiota and inflammasomes interplay in health and disease: a gut feeling
Luca, R. D., Arrè, V., Nardone, S., Incerpi, S., Giannelli, G., Trivedi, P., Anastasiadou, E., & Negro, R. (2025) · Gut · doi:10.1136/gutjnl-2025-334938 · Cited by 37
“15 The eubiosis phenotype is age-dependent and constantly influenced by the host genome, prolonged broad-spectrum antibiotic usage and environmental and lifestyle factors, which define the biological diversity among individuals.”
Laurans, L., Mouttoulingam, N., Chajadine, M., Lavelle, A., Diedisheim, M., Bacquer, E., Creusot, L., Suffee, N., Esposito, B., Melhem, N. J., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113350 · Cited by 34
Influence of Microbiota on Tumor Immunotherapy
Yu, X., Li, W., Li, Z., Wu, Q., & Sun, S. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.91771 · Cited by 37
“A study by Gil-Cruz et al. elucidated how shared structural features between a β -galactosidase enzyme derived from Bacteroides thetaiotaomicron and host cardiac myosin heavy chain-6 could instigate a devastating autoimmune myocarditis condition [188].”
BackgroundJiang, H., Yu, Y., Hu, X., Du, B., Shao, Y., Wang, F., Chen, L., Yan, R., Li, L., & Lv, L. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2383353 · Cited by 36
“33 Therefore, these results indicate that the mouse flora obtained after FMT has a material basis that reflects the pathological function of the microbiota of PBC patients.”
BackgroundAntigenic mimicry – The key to autoimmunity in immune privileged organs
Wildner, G. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102942 · Cited by 34
Triggers of Inflammatory Heart Disease
Lasrado, N., Yalaka, B., & Reddy, J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00192 · Cited by 35
“These findings suggest that the microbiome could predispose genetically susceptible individuals undergoing checkpoint inhibitors to develop myocarditis, leading to the suggestion that they can potentially be treated with antibiotics (Gil-Cruz et al., 2019).”
BackgroundResultFragasso, G., Stolfo, D., Anker, M. S., Bayés‐Genís, A., Chioncel, O. D., Heymans, S. R. B., Jhund, P. S., Lewis, B. S., Lopaschuk, G. D., Lund, L. H., et al. (2025) · European Journal of Heart Failure · doi:10.1002/ejhf.3703 · Cited by 38
Huang, J., Lin, Y., Ding, X., Lin, S., Li, X., Yan, W., & Chen, M. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.106647 · Cited by 35
You, L., Zhou, J., Xin, Z., Hauck, J. S., Na, F., Tang, J., Zhou, X., Lei, Z., & Ying, B. (2022) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbac005 · Cited by 35
Perturbed Microbiota/Immune Homeostasis in Multiple Sclerosis
Sterlin, D., Larsen, M., Fadlallah, J., Parizot, C., Vignes, M., Autaa, G., Dorgham, K., Juste, C., Lepage, P., Aboab, J., et al. (2021) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000997 · Cited by 31
Bugs as drugs: The role of microbiome in cancer focusing on immunotherapeutics
Araujo, D. V., Watson, G. A., Oliva, M., Heirali, A., Coburn, B., Spreafico, A., & Siu, L. L. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.102125 · Cited by 29
Circulating T Cells and Cardiovascular Risk in People With and Without HIV Infection
Kundu, S., Freiberg, M. S., Tracy, R. P., So‐Armah, K., Koethe, J. R., Duncan, M. S., Tindle, H. A., Beckman, J. A., Feinstein, M. J., McDonnell, W. J., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.08.756 · Cited by 28
Long-term simulated microgravity alters gut microbiota and metabolome in mice
Lu, Y., Zhang, R., Li, X., Gao, C., Hu, X., Hussain, S., Zhang, L., Wang, M., Ma, X., Pan, Q., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1100747 · Cited by 29
“may trigger autoimmunity accompanied by cardiomyopathy (Gil-Cruz et al., 2019).”
Immunomodulation of Myocardial Fibrosis
Sikking, M. A., Stroeks, S. L. V. M., Marelli‐Berg, F. M., Heymans, S. R. B., Ludewig, B., & Verdonschot, J. A. J. (2023) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2023.03.015 · Cited by 31
Self-citationGut Bacteria—Not for the Faint of Heart
Mandelbaum, N., Gefen, T., & Geva‐Zatorsky, N. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2019.12.011 · Cited by 27
Microbiome-based interventions: therapeutic strategies in cancer immunotherapy
Chervin, C. S., & Gajewski, T. F. (2020) · Immuno-Oncology Technology · doi:10.1016/j.iotech.2020.11.001 · Cited by 29
“autoimmune reaction).(52) Similarly, modulation of the intestinal microbiota with oral administration of Bifidobacterium spp.”
BackgroundInfluence of the microbiome on solid organ transplant survival
Pirozzolo, I., Li, Z., Sepulveda, M., & Alegre, M. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.04.004 · Cited by 27
Metadata
- Authors
- Gil-Cruz, C., Perez-Shibayama, C., De Martin, A., Ronchi, F., van der Borght, K., Niederer, R., Onder, L., Lütge, M., Novkovic, M., Nindl, V., Ramos, G., Arnoldini, M., Slack, E. M. C., Boivin-Jahns, V., Jahns, R., Wyss, M., Mooser, C., Lambrecht, B. N., Maeder, M. T., Rickli, H., Flatz, L., Eriksson, U., Geuking, M. B., McCoy, K. D., & Ludewig, B.
- Affiliations
- Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
- University of Bern (CH)
- VIB Center for Inflammation Research, Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
- Kantonsspital St. Gallen (CH)
- Universitätsklinikum Würzburg (DE)
- ETH Zurich (CH)
- Comprehensive Heart Failure Center, University Hospital of Würzburg, Würzburg, Germany.
- University of Calgary (CA)
- Ghent University (BE)
- University of Zurich (CH)
- Corresponding author
- Ludewig, Burkhard
- ORCID
- Venue
- Science
- Published
- 2019-11-15
- Volume
- 366
- Issue
- 6467
- Pages
- 881-886
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2988477155
- Cited by
- 260
- References
- 38
- Citations by year
- 2026: 25 · 2025: 25 · 2024: 38 · 2023: 51 · 2022: 49 · 2021: 37 · 2020: 31 · 2019: 3
- FWCI
- 21.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Bern Open Repository and Information System (University of Bern) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Funders
- Swiss National Science Foundation (130823, 146133)
- Bundesministerium für Bildung und Forschung (FKZ 01ES0901, FKZ 01ES0802)
- Interdisciplinary Centre for Clinical Research, Universität of Würzburg, Germany (E-354)
- Interdisciplinary Centre for Clinical Research (E-32)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- inflammatory cardiomyopathy, myocarditis, peptide mimicry, commensal gut microbiota, Bacteroides, T helper cells, autoimmunity, heart failure, antibiotic therapy, mouse model
- MeSH terms
- Gastrointestinal Microbiome, Animals, Autoimmune Diseases, B-Lymphocytes, Bacteroides, beta-Galactosidase, Cardiomyopathy, Dilated, Disease Models, Animal, Humans, Intestines, Mice, Inbred BALB C, Mice, Transgenic, Myocarditis, Peptides, CD4-Positive T-Lymphocytes, Myosin Heavy Chains, Mice, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.